- Home
- MMA vs PHGE Comparison
MMA vs PHGE Comparison
Compare MMA & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- PHGE
- Stock Information
- Founded
- MMA 2013
- PHGE 2015
- Country
- MMA Australia
- PHGE Israel
- Employees
- MMA N/A
- PHGE N/A
- Industry
- MMA
- PHGE Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- PHGE Health Care
- Exchange
- MMA Nasdaq
- PHGE Nasdaq
- Market Cap
- MMA 11.1M
- PHGE 10.4M
- IPO Year
- MMA 2024
- PHGE N/A
- Fundamental
- Price
- MMA $1.74
- PHGE $0.47
- Analyst Decision
- MMA
- PHGE Strong Buy
- Analyst Count
- MMA 0
- PHGE 1
- Target Price
- MMA N/A
- PHGE $15.00
- AVG Volume (30 Days)
- MMA 10.9M
- PHGE 441.1K
- Earning Date
- MMA 01-01-0001
- PHGE 08-13-2025
- Dividend Yield
- MMA N/A
- PHGE N/A
- EPS Growth
- MMA N/A
- PHGE N/A
- EPS
- MMA N/A
- PHGE N/A
- Revenue
- MMA $407,412.00
- PHGE N/A
- Revenue This Year
- MMA N/A
- PHGE N/A
- Revenue Next Year
- MMA N/A
- PHGE N/A
- P/E Ratio
- MMA N/A
- PHGE N/A
- Revenue Growth
- MMA N/A
- PHGE N/A
- 52 Week Low
- MMA $0.60
- PHGE $0.34
- 52 Week High
- MMA $4.11
- PHGE $1.16
- Technical
- Relative Strength Index (RSI)
- MMA 76.80
- PHGE 44.76
- Support Level
- MMA $0.80
- PHGE $0.45
- Resistance Level
- MMA $3.07
- PHGE $0.51
- Average True Range (ATR)
- MMA 0.25
- PHGE 0.03
- MACD
- MMA 0.10
- PHGE -0.01
- Stochastic Oscillator
- MMA 41.16
- PHGE 19.83
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).